Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 11.40% is 28% below its 5-year average of 15.83%, near the low end of its 5-year range (10.74%–20.09%).
As of the fiscal period ended Wednesday, December 31, 2025. 2.98% above its 12-month average of 11.07%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
11.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
11.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
15.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
16.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
15.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
14.93%
CURRENT VS TTM AVG
+2.98%
CURRENT VS 3Y AVG
-21.00%
CURRENT VS 5Y AVG
-27.97%
CURRENT VS 10Y AVG
-29.42%
CURRENT VS 15Y AVG
-27.28%
CURRENT VS 20Y AVG
-23.64%
SECTOR MEDIAN · HEALTHCARE
8.78%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+29.84%
vs the sector median at left
Edwards Lifesciences Corporation
Market Cap
$53.68B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
Market Cap
$55.64B
Return on Invested Capital (ROIC)
N/A
TTM Avg
3.45%
3Y Avg
7.87%
5Y Avg
4.57%
Market Cap
$50.26B
Return on Invested Capital (ROIC)
4.73%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$46.17B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$45.27B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$62.17B
Return on Invested Capital (ROIC)
13.23%
TTM Avg
15.09%
3Y Avg
14.58%
5Y Avg
13.58%
Market Cap
$41.86B
Return on Invested Capital (ROIC)
12.57%
TTM Avg
12.57%
3Y Avg
13.57%
5Y Avg
12.73%
Market Cap
$39.97B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$34.16B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $53.68B | 11.40% | 11.07% | 14.43% | 15.83% |
| Cardinal Health, Inc. (CAH)vs › | $55.64B | N/A | 3.45% | 7.87% | 4.57% |
| Becton, Dickinson and Company (BDX)vs › | $50.26B | 4.73% | 4.38% | 4.32% | 3.88% |
| Humana Inc. (HUM)vs › | $46.17B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $45.27B | 40.27% | 37.07% | 34.89% | 35.94% |
| Cencora, Inc. (COR)vs › | $62.17B | 13.23% | 15.09% | 14.58% | 13.58% |
| Agilent Technologies, Inc. (A)vs › | $41.86B | 12.57% | 12.57% | 13.57% | 12.73% |
| IQVIA Holdings Inc. (IQV)vs › | $39.97B | 8.23% | 8.41% | 8.23% | 6.99% |
| DexCom, Inc. (DXCM)vs › | $34.16B | 16.61% | 13.40% | 11.07% | 9.62% |
| Cigna Corporation (CI)vs › | $73.51B | 7.35% | 7.02% | 7.07% | 6.50% |
ROIC
11.4%
ROE
9.5%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 11.40% |
| 2024-12-31 | 10.74% |
| 2023-12-31 | 15.49% |
| 2022-12-31 | 20.09% |
| 2021-12-31 | 18.97% |
| 2020-12-31 | 18.27% |
| 2019-12-31 | 19.16% |
| 2018-12-31 | 23.30% |
| 2017-12-31 | 11.64% |
| 2016-12-31 | 15.82% |
| 2015-12-31 | 12.78% |
| 2014-12-31 | 11.18% |
| 2013-12-31 | 13.83% |
| 2012-12-31 | 15.87% |
| 2011-12-31 | 16.69% |
| 2010-12-31 | 15.61% |
| 2009-12-31 | 13.23% |
| 2008-12-31 | 14.35% |
| 2007-12-31 | 11.42% |
| 2006-12-31 | 12.13% |
| 2005-12-31 | 11.53% |
| 2004-12-31 | 0.95% |
| 2003-12-31 | 12.61% |
| 2002-12-31 | 6.40% |
| 2001-12-31 | 3.04% |
| 2000-12-31 | 10.22% |
| 1999-12-31 | 6.63% |
